Assured Pharmacy Inc (APHY) financial statements (2020 and earlier)

Company profile

Business Address 5600 TENNYSON PARKWAY
PLANO, TX 75024
State of Incorp. NV
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 321
Cash and cash equivalents 321
Receivables 324677
Disposal group, including discontinued operation 4 
Prepaid expense and other current assets147
Other undisclosed current assets 499410
Total current assets: 8301,256
Noncurrent Assets
Property, plant and equipment 7861
Intangible assets, net (including goodwill) 698
Goodwill  698
Assets of disposal group, including discontinued operation141 
Other undisclosed noncurrent assets  207
Total noncurrent assets: 219966
TOTAL ASSETS: 1,0492,221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,6434,850
Accrued liabilities 39 
Other undisclosed accounts payable and accrued liabilities 1,6034,850
Debt 4263,000
Other undisclosed current liabilities 508(282)
Total current liabilities: 2,5777,568
Noncurrent Liabilities
Liabilities, other than long-term debt 789447
Due to related parties 477447
Derivative instruments and hedges, liabilities 312 
Other undisclosed noncurrent liabilities 5,633694
Total noncurrent liabilities: 6,4221,141
Total liabilities: 8,9998,709
Stockholders' equity
Stockholders' equity attributable to parent, including: (10,466)(6,487)
Common stock 104
Additional paid in capital 38,14236,572
Accumulated deficit (48,618)(43,064)
Warrants and rights outstanding 1,060275
Other undisclosed stockholders' equity attributable to parent (1,060)(275)
Other undisclosed stockholders' equity 2,515 
Total stockholders' equity: (7,950)(6,487)
TOTAL LIABILITIES AND EQUITY: 1,0492,221

Income statement (P&L) ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Revenues 5,19314,146
Revenue, net 9,734 
Cost of revenue (4,072)(11,078)
Cost of goods and services sold (1,741) 
Gross profit: 1,1203,067
Operating expenses (4,020)(5,864)
Other operating income (expense), net
(Other Expenses)
 (475)1,208
Other undisclosed operating loss  (1,208)
Operating loss: (3,375)(2,797)
Interest and debt expense 287(1,566)
Other undisclosed income from continuing operations before equity method investments, income taxes 336 
Loss from continuing operations before equity method investments, income taxes: (2,752)(4,363)
Other undisclosed loss from continuing operations before income taxes (2,193) 
Loss from continuing operations before income taxes: (4,945)(4,363)
Income tax expense (benefit) (328)1,362
Other undisclosed loss from continuing operations  (1,005)
Loss from continuing operations: (5,273)(4,006)
Loss from discontinued operations (609) 
Net loss: (5,882)(4,006)
Other undisclosed net income attributable to parent 2,521 
Net loss attributable to parent: (3,362)(4,006)
Preferred stock dividends and other adjustments (2,193) 
Net loss available to common stockholders, diluted: (5,554)(4,006)

Comprehensive Income ($ in thousands)

9/30/2014
TTM
12/31/2013
12/31/2012
Net loss: (5,882)(4,006)
Comprehensive loss, net of tax, attributable to parent: (5,882)(4,006)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: